A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug-drug interactions

Abstract Dasatinib, a second‐generation tyrosine kinase inhibitor, is approved for treating chronic myeloid and acute lymphoblastic leukemia. As a sensitive cytochrome P450 (CYP) 3A4 substrate and weak base with strong pH‐sensitive solubility, dasatinib is susceptible to enzyme‐mediated drug-drug in...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Christina Kovar (Dahkki), Helena Leonie Hanae Loer (Dahkki), Simeon Rüdesheim (Dahkki), Laura Maria Fuhr (Dahkki), Fatima Zahra Marok (Dahkki), Dominik Selzer (Dahkki), Matthias Schwab (Dahkki), Thorsten Lehr (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Wiley, 2024-07-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis